{"count": 64, "results": [{"_id": "36139772", "pmid": 36139772, "pmcid": "PMC9495827", "title": "Coenzyme Q10 Supplementation in Statin Treated Patients: A Double-Blinded Randomized Placebo-Controlled Trial", "journal": "Antioxidants (Basel)", "authors": ["Dohlmann TL", "Kuhlman AB", "Morville T", "Dahl M", "Asping M", "Orlando P", "Silvestri S", "Tiano L", "Helge JW", "Dela F", "Larsen S"], "date": "2022-08-29T00:00:00Z", "doi": "10.3390/antiox11091698", "meta_date_publication": "2022 Aug 29", "meta_volume": "11", "meta_issue": "9", "meta_pages": "", "score": 50267.668, "text_hl": "@SPECIES_9606 @@@Patients@@@ in primary prevention with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ minimum 40 mg daily, who met the inclusion criteria (age 40-70 years, body mass index 25-35 kg m-2), were invited for a personal interview where they described their history of statin use and, if any, symptoms of @<m>DISEASE_Myalgia</m> @DISEASE_MESH:D063806 @@@muscle pain@@@. ", "citations": {"NLM": "Dohlmann TL, Kuhlman AB, Morville T, Dahl M, Asping M, Orlando P, Silvestri S, Tiano L, Helge JW, Dela F, Larsen S. Coenzyme Q10 Supplementation in Statin Treated Patients: A Double-Blinded Randomized Placebo-Controlled Trial Antioxidants (Basel). 2022 Aug 29;11(9):. PMID: 36139772", "BibTeX": "@article{36139772, title={Coenzyme Q10 Supplementation in Statin Treated Patients: A Double-Blinded Randomized Placebo-Controlled Trial}, author={Dohlmann TL and Kuhlman AB and Morville T and Dahl M and Asping M and Orlando P and Silvestri S and Tiano L and Helge JW and Dela F and Larsen S}, journal={Antioxidants (Basel)}, volume={11}, number={9}}"}}, {"_id": "35359432", "pmid": 35359432, "pmcid": "PMC8964290", "title": "Simvastatin and Muscle: Zebrafish and Chicken Show that the Benefits are not Worth the Damage", "journal": "Front Cell Dev Biol", "authors": ["Campos LM", "Guapyassu L", "Gomes C", "Midlej V", "Benchimol M", "Mermelstein C", "Costa ML"], "date": "2022-03-14T00:00:00Z", "doi": "10.3389/fcell.2022.778901", "meta_date_publication": "2022", "meta_volume": "10", "meta_issue": "", "meta_pages": "778901", "score": 50262.598, "text_hl": "Unfortunately, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ causes unwanted side effects on muscles, such as @<m>DISEASE_Myalgia</m> @DISEASE_MESH:D063806 @@@soreness@@@, tiredness, or @DISEASE_Muscle_Weakness @DISEASE_MESH:D018908 @@@weakness@@@. ", "citations": {"NLM": "Campos LM, Guapyassu L, Gomes C, Midlej V, Benchimol M, Mermelstein C, Costa ML. Simvastatin and Muscle: Zebrafish and Chicken Show that the Benefits are not Worth the Damage Front Cell Dev Biol. 2022;10():778901. PMID: 35359432", "BibTeX": "@article{35359432, title={Simvastatin and Muscle: Zebrafish and Chicken Show that the Benefits are not Worth the Damage}, author={Campos LM and Guapyassu L and Gomes C and Midlej V and Benchimol M and Mermelstein C and Costa ML}, journal={Front Cell Dev Biol}, volume={10}, pages={778901}}"}}, {"_id": "40576487", "pmid": 40576487, "title": "Safety of Concomitant Use of Tacrolimus and High-Intensity Statins in Liver and Kidney Transplant Recipients.", "journal": "Prog Transplant", "authors": ["Klein K", "Klimatcheva M", "Hall R", "Patel R", "Speeg KV", "Guerrero J", "Long C"], "date": "2025-09-01T00:00:00Z", "doi": "10.1177/15269248251349768", "meta_date_publication": "2025 Sep", "meta_volume": "35", "meta_issue": "3", "meta_pages": "178-182", "score": 50249.055, "text_hl": "Due to increased risk of @<m>DISEASE_Myalgia</m> @DISEASE_MESH:D063806 @@@myalgia@@@ and @DISEASE_Rhabdomyolysis @DISEASE_MESH:D012206 @@@rhabdomyolysis@@@ associated with the use of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ with @CHEMICAL_Cyclosporine @CHEMICAL_MESH:D016572 @@@cyclosporine@@@, use of high-intensity 3-hydroxy-3-methylglutaryl Coenzyme A reductase inhibitors (statins) is often avoided in transplant recipients. ", "citations": {"NLM": "Klein K, Klimatcheva M, Hall R, Patel R, Speeg KV, Guerrero J, Long C. Safety of Concomitant Use of Tacrolimus and High-Intensity Statins in Liver and Kidney Transplant Recipients. Prog Transplant. 2025 Sep;35(3):178-182. PMID: 40576487", "BibTeX": "@article{40576487, title={Safety of Concomitant Use of Tacrolimus and High-Intensity Statins in Liver and Kidney Transplant Recipients.}, author={Klein K and Klimatcheva M and Hall R and Patel R and Speeg KV and Guerrero J and Long C}, journal={Prog Transplant}, volume={35}, number={3}, pages={178-182}}"}}, {"_id": "32469304", "pmid": 32469304, "title": "Pharmacodynamic evaluation of L-carnitine and piracetam in muscle injury induced by the chronic use of simvastatin.", "journal": "Int J Clin Pharmacol Ther", "authors": ["Dezena RMB", "Antunes NJ", "Campos R", "Ilha J", "Moreno RA", "Mendes GD", "Rosa PCP", "De Nucci G"], "date": "2020-09-01T00:00:00Z", "doi": "10.5414/CP203496", "meta_date_publication": "2020 Sep", "meta_volume": "58", "meta_issue": "9", "meta_pages": "482-490", "score": 50248.156, "text_hl": "CONCLUSION: Concomitant use of @CHEMICAL_Carnitine @CHEMICAL_MESH:D002331 @@@L-carnitine@@@ and @CHEMICAL_Piracetam @CHEMICAL_MESH:D010889 @@@piracetam@@@ might have a muscle-protective effect and protection against @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-induced @<m>DISEASE_Myalgia</m> @DISEASE_MESH:D063806 @@@myalgia@@@. ", "citations": {"NLM": "Dezena RMB, Antunes NJ, Campos R, Ilha J, Moreno RA, Mendes GD, Rosa PCP, De Nucci G. Pharmacodynamic evaluation of L-carnitine and piracetam in muscle injury induced by the chronic use of simvastatin. Int J Clin Pharmacol Ther. 2020 Sep;58(9):482-490. PMID: 32469304", "BibTeX": "@article{32469304, title={Pharmacodynamic evaluation of L-carnitine and piracetam in muscle injury induced by the chronic use of simvastatin.}, author={Dezena RMB and Antunes NJ and Campos R and Ilha J and Moreno RA and Mendes GD and Rosa PCP and De Nucci G}, journal={Int J Clin Pharmacol Ther}, volume={58}, number={9}, pages={482-490}}"}}, {"_id": "34187111", "pmid": 34187111, "pmcid": "PMC8265195", "title": "Drug-drug-gene Interactions as Mediators of Adverse Drug Reactions to Diclofenac and Statins: A Case Report and Literature Review", "journal": "Arh Hig Rada Toksikol", "authors": ["Božina N", "Ganoci L", "Simičević L", "Gvozdanović K", "Domjanović IK", "Fistrek Prlić M", "Križ T", "Borić Bilušić A", "Laganović M", "Božina T"], "date": "2021-06-28T00:00:00Z", "doi": "10.2478/aiht-2021-72-3549", "meta_date_publication": "2021 Jun 28", "meta_volume": "72", "meta_issue": "3", "meta_pages": "114-128", "score": 50241.062, "text_hl": "In that light, we present a case of a 46-year-old @SPECIES_9606 @@@woman@@@ who had been experiencing @DISEASE_Liver_Failure_Acute @DISEASE_MESH:D017114 @@@acute renal and hepatic injury@@@ and @<m>DISEASE_Myalgia</m> @DISEASE_MESH:D063806 @@@myalgia@@@ over two years of concomitant treatment with @CHEMICAL_Diclofenac @CHEMICAL_MESH:D004008 @@@diclofenac@@@, @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@/@CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@, and several other drugs, including @CHEMICAL_Pantoprazole @CHEMICAL_MESH:D000077402 @@@pantoprazole@@@ and @CHEMICAL_Furosemide @CHEMICAL_MESH:D005665 @@@furosemide@@@. ", "citations": {"NLM": "Božina N, Ganoci L, Simičević L, Gvozdanović K, Domjanović IK, Fistrek Prlić M, Križ T, Borić Bilušić A, Laganović M, Božina T. Drug-drug-gene Interactions as Mediators of Adverse Drug Reactions to Diclofenac and Statins: A Case Report and Literature Review Arh Hig Rada Toksikol. 2021 Jun 28;72(3):114-128. PMID: 34187111", "BibTeX": "@article{34187111, title={Drug-drug-gene Interactions as Mediators of Adverse Drug Reactions to Diclofenac and Statins: A Case Report and Literature Review}, author={Božina N and Ganoci L and Simičević L and Gvozdanović K and Domjanović IK and Fistrek Prlić M and Križ T and Borić Bilušić A and Laganović M and Božina T}, journal={Arh Hig Rada Toksikol}, volume={72}, number={3}, pages={114-128}}"}}, {"_id": "32124390", "pmid": 32124390, "title": "Adverse effects of interactions between antipsychotics and medications used in the treatment of cardiovascular disorders.", "journal": "Pharmacol Rep", "authors": ["Siwek M", "Woroń J", "Gorostowicz A", "Wordliczek J"], "date": "2020-04-01T00:00:00Z", "doi": "10.1007/s43440-020-00058-6", "meta_date_publication": "2020 Apr", "meta_volume": "72", "meta_issue": "2", "meta_pages": "350-359", "score": 50229.758, "text_hl": "RESULTS: The highest number of interactions with antipsychotics was recorded among beta-blockers (n = 13, 25% of all cases), including @DISEASE_Arrhythmias_Cardiac @DISEASE_MESH:D001145 @@@cardiac arrhythmias@@@ [@DISEASE_Atrial_Fibrillation @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ (n = 1): @CHEMICAL_Risperidone @CHEMICAL_MESH:D018967 @@@risperidone@@@ plus @CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@; @DISEASE_Bradycardia @DISEASE_MESH:D001919 @@@bradycardia@@@ (n = 1): @CHEMICAL_Perphenazine @CHEMICAL_MESH:D010546 @@@perphenazine@@@ with @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@; @DISEASE_Arrhythmias_Cardiac @DISEASE_MESH:D001145 @@@ventricular arrhythmias@@@: @CHEMICAL_sertindole @CHEMICAL_MESH:C066304 @@@sertindole@@@ with @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ (n = 1) and @CHEMICAL_ziprasidone @CHEMICAL_MESH:C092292 @@@ziprasidone@@@ with @CHEMICAL_Sotalol @CHEMICAL_MESH:D013015 @@@sotalol@@@ (n = 3)] and @DISEASE_Hypotension @DISEASE_MESH:D007022 @@@hypotension@@@ [@CHEMICAL_Chlorprothixene @CHEMICAL_MESH:D002749 @@@chlorprotixene@@@ with @CHEMICAL_Nebivolol @CHEMICAL_MESH:D000068577 @@@nebivolol@@@ or @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ (n = 2)]. 12 cases concerned statins-@<m>DISEASE_Myalgia</m> @DISEASE_MESH:D063806 @@@myalgia@@@, @DISEASE_Muscular_Diseases @DISEASE_MESH:D009135 @@@myopathy@@@, or creatine kinase elevation appeared after combination of @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ with @CHEMICAL_Haloperidol @CHEMICAL_MESH:D006220 @@@haloperidol@@@ (n = 1), @CHEMICAL_Quetiapine_Fumarate @CHEMICAL_MESH:D000069348 @@@quetiapine@@@ (n = 3) or @CHEMICAL_Risperidone @CHEMICAL_MESH:D018967 @@@risperidone@@@ (n = 1), and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ with @CHEMICAL_Quetiapine_Fumarate @CHEMICAL_MESH:D000069348 @@@quetiapine@@@ (n = 5) or @CHEMICAL_Risperidone @CHEMICAL_MESH:D018967 @@@risperidone@@@ (n = 2). ", "citations": {"NLM": "Siwek M, Woroń J, Gorostowicz A, Wordliczek J. Adverse effects of interactions between antipsychotics and medications used in the treatment of cardiovascular disorders. Pharmacol Rep. 2020 Apr;72(2):350-359. PMID: 32124390", "BibTeX": "@article{32124390, title={Adverse effects of interactions between antipsychotics and medications used in the treatment of cardiovascular disorders.}, author={Siwek M and Woroń J and Gorostowicz A and Wordliczek J}, journal={Pharmacol Rep}, volume={72}, number={2}, pages={350-359}}"}}, {"_id": "26257959", "pmid": 26257959, "pmcid": "PMC4518173", "title": "Effect of Simvastatin on Arterial Stiffness in Patients with Statin Myalgia", "journal": "Adv Prev Med", "authors": ["Ballard KD", "Lorson L", "White CM", "Thompson PD", "Taylor BA"], "date": "2015-01-01T00:00:00Z", "doi": "10.1155/2015/351059", "meta_date_publication": "2015", "meta_volume": "2015", "meta_issue": "", "meta_pages": "351059", "score": 50089.297, "text_hl": "Effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ on Arterial Stiffness in @SPECIES_9606 @@@Patients@@@ with Statin @<m>DISEASE_Myalgia</m> @DISEASE_MESH:D063806 @@@Myalgia@@@", "citations": {"NLM": "Ballard KD, Lorson L, White CM, Thompson PD, Taylor BA. Effect of Simvastatin on Arterial Stiffness in Patients with Statin Myalgia Adv Prev Med. 2015;2015():351059. PMID: 26257959", "BibTeX": "@article{26257959, title={Effect of Simvastatin on Arterial Stiffness in Patients with Statin Myalgia}, author={Ballard KD and Lorson L and White CM and Thompson PD and Taylor BA}, journal={Adv Prev Med}, volume={2015}, pages={351059}}"}}, {"_id": "12793123", "pmid": 12793123, "title": "[Generalized muscle pain in a 67-year-old patient. Myalgia/myositis in therapy with Zocor].", "journal": "Praxis (Bern 1994)", "authors": ["Rogge N"], "date": "2003-05-14T00:00:00Z", "doi": "10.1024/0369-8394.92.20.965", "meta_date_publication": "2003 May 14", "meta_volume": "92", "meta_issue": "20", "meta_pages": "965-8", "score": 50082.492, "text_hl": "@<m>DISEASE_Myalgia</m> @DISEASE_MESH:D063806 @@@Myalgia@@@/@DISEASE_Myositis @DISEASE_MESH:D009220 @@@myositis@@@ in therapy with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Zocor@@@].", "citations": {"NLM": "Rogge N. [Generalized muscle pain in a 67-year-old patient. Myalgia/myositis in therapy with Zocor]. Praxis (Bern 1994). 2003 May 14;92(20):965-8. PMID: 12793123", "BibTeX": "@article{12793123, title={[Generalized muscle pain in a 67-year-old patient. Myalgia/myositis in therapy with Zocor].}, author={Rogge N}, journal={Praxis (Bern 1994)}, volume={92}, number={20}, pages={965-8}}"}}, {"_id": "17950797", "pmid": 17950797, "title": "Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.", "journal": "Am J Cardiol", "authors": ["Young JM", "Florkowski CM", "Molyneux SL", "McEwan RG", "Frampton CM", "George PM", "Scott RS"], "date": "2007-11-01T00:00:00Z", "doi": "10.1016/j.amjcard.2007.06.030", "meta_date_publication": "2007 Nov 1", "meta_volume": "100", "meta_issue": "9", "meta_pages": "1400-3", "score": 50078.754, "text_hl": "Effect of @CHEMICAL_coenzyme_Q10 @CHEMICAL_MESH:C024989 @@@coenzyme Q(10)@@@ supplementation on @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-induced @<m>DISEASE_Myalgia</m> @DISEASE_MESH:D063806 @@@myalgia@@@.", "citations": {"NLM": "Young JM, Florkowski CM, Molyneux SL, McEwan RG, Frampton CM, George PM, Scott RS. Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. Am J Cardiol. 2007 Nov 1;100(9):1400-3. PMID: 17950797", "BibTeX": "@article{17950797, title={Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.}, author={Young JM and Florkowski CM and Molyneux SL and McEwan RG and Frampton CM and George PM and Scott RS}, journal={Am J Cardiol}, volume={100}, number={9}, pages={1400-3}}"}}, {"_id": "23929614", "pmid": 23929614, "title": "Should anyone still be taking simvastatin 80 mg?", "journal": "BMJ Case Rep", "authors": ["Tayal U", "Carroll R"], "date": "2013-08-08T00:00:00Z", "doi": "10.1136/bcr-2013-200415", "meta_date_publication": "2013 Aug 8", "meta_volume": "2013", "meta_issue": "", "meta_pages": "", "score": 50075.156, "text_hl": "A 64-year-old @SPECIES_9606 @@@woman@@@ who previously suffered @<m>DISEASE_Myalgia</m> @DISEASE_MESH:D063806 @@@myalgia@@@ with lower dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ was given just one high dose of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and developed @DISEASE_Rhabdomyolysis @DISEASE_MESH:D012206 @@@rhabdomyolysis@@@. ", "citations": {"NLM": "Tayal U, Carroll R. Should anyone still be taking simvastatin 80 mg? BMJ Case Rep. 2013 Aug 8;2013():. PMID: 23929614", "BibTeX": "@article{23929614, title={Should anyone still be taking simvastatin 80 mg?}, author={Tayal U and Carroll R}, journal={BMJ Case Rep}, volume={2013}}"}}]}